A French antidepressant sold at gas stations acts on opioid receptors
In short: Tianeptine is sold as a dietary supplement in many American gas stations, yet it began as a prescription antidepressant in France. Its effects on the brain resemble those of opioids, which explains its nickname, gas station heroin. Understanding why it is unregulated, and why health authorities warn against it, reveals how supplement loopholes can hide powerful drugs.
Tianeptine was first developed in France during the 1960s, and it reached patients there in the early 1980s as an antidepressant. Providers in Europe can still prescribe it, but only as a controlled substance. It has never been approved by the U.S. Food and Drug Administration for depression or any other condition, and it never received the agency's Generally Recognized as Safe designation. The drug works differently from most antidepressants. Rather than simply raising mood-related chemicals, it binds to the brain's opioid receptors, the same receptors targeted by heroin and morphine. Researchers describe it as an atypical agonist of the mu-opioid receptor, and some evidence suggests it also affects glutamate receptors. Clinical studies have reported antidepressant and anxiety-reducing effects with fewer cardiovascular and sedative side effects than older tricyclic drugs. Trials have also explored its use for irritable bowel syndrome, asthma, fibromyalgia and attention-deficit hyperactivity disorder, though these findings come from specific studies and are not universally accepted. The central problem is addiction. Clinicians found early on that patients sought more of the drug and suffered withdrawal when they stopped abruptly.
Because it can produce euphoria at doses well above the therapeutic range, it is considered risky for anyone with a history of substance abuse. Severe withdrawal can follow prolonged use at high doses, so stopping treatment requires careful medical supervision. In the United States the situation is different. Some companies have marketed tianeptine as a dietary supplement, sometimes described as a nootropic, and the product is not subject to the same regulation as prescription medicines. Analyses have found that some products contain other recreational drugs, and commercial products may contain far more than a normal therapeutic dose. In early 2024, federal health researchers recorded twenty people in New Jersey who needed medical care after using the substance, thirteen of them in intensive care, though no deaths were reported. Several states have banned the substance, and in July 2026 the Drug Enforcement Administration announced plans to classify it as a Schedule I controlled substance.
Tianeptine illustrates a broader lesson about the word natural and about regulation. Its manufacture in a laboratory is a reminder that a product sold beside snacks can still be a synthetic pharmaceutical with potent effects. Clinicians emphasize that newer medications offer safer and more effective treatment for mood and anxiety disorders, and they advise anyone considering a supplement to consult a doctor first.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Know the Dangers of ‘Gas Station Heroin’
- Also: Tianeptine
To cite this card, link to https://intellectplus.co.uk/app/health-tianeptine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicines · More in Health · Latest · A–Z · All topics